Ignite Creation Date:
2024-05-06 @ 1:44 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01888744
Status:
COMPLETED
Last Update Posted:
2013-06-28
First Post:
2013-06-21
Brief Title:
Preimplantation Genetic Diagnosis PGD With Gonadotropin-releasing Hormone GnRH Agonist Versus Antagonist
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Universitair Ziekenhuis Brussel
Study Overview
Official Title:
The Effect of the Type of Ovarian Stimulation Protocol on PGD Results a Prospective Randomised Trial
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Avanti
Brief Summary:
The aim of our study is to define the optimal ovarian stimulation protocol concerning PGD and for this reason we plan a randomized controlled trial RCT comparing gonadotropin-releasing hormone GnRH agonist protocol versus GnRH antagonist protocol The follicle stimulating hormone FSH preparation in both arms will be highly purified FSH Menopur
Detailed Description:
Patients will be randomized at the outpatient clinic in two groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None